These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35543128)

  • 21. Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease.
    Morimoto T; Mineharu Y; Ono K; Nakatochi M; Ichihara S; Kabata R; Takagi Y; Cao Y; Zhao L; Kobayashi H; Harada KH; Takenaka K; Funaki T; Yokota M; Matsubara T; Yamamoto K; Izawa H; Kimura T; Miyamoto S; Koizumi A
    PLoS One; 2017; 12(4):e0175649. PubMed ID: 28414759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different subtypes of collateral vessels in hemorrhagic moyamoya disease with p.R4810K variant.
    Ge P; Zhang Q; Ye X; Liu X; Deng X; Wang J; Wang R; Zhang Y; Zhang D; Zhao J
    BMC Neurol; 2020 Aug; 20(1):308. PubMed ID: 32814565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNF213 Rare Variants in Slovakian and Czech Moyamoya Disease Patients.
    Kobayashi H; Brozman M; Kyselová K; Viszlayová D; Morimoto T; Roubec M; Školoudík D; Petrovičová A; Juskanič D; Strauss J; Halaj M; Kurray P; Hranai M; Harada KH; Inoue S; Yoshida Y; Habu T; Herzig R; Youssefian S; Koizumi A
    PLoS One; 2016; 11(10):e0164759. PubMed ID: 27736983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Moyamoya and Middle Cerebral Artery Diseases by Carotid Canal Diameter and RNF213 p.R4810K Genotype.
    Oichi Y; Mineharu Y; Agawa Y; Morimoto T; Funaki T; Hitomi T; Kobayashi H; Todo K; Tani S; Imamura H; Yoshida K; Kataoka H; Koizumi A; Sakai N; Miyamoto S
    J Stroke Cerebrovasc Dis; 2022 Jun; 31(6):106481. PubMed ID: 35430511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population.
    Wu Z; Jiang H; Zhang L; Xu X; Zhang X; Kang Z; Song D; Zhang J; Guan M; Gu Y
    PLoS One; 2012; 7(10):e48179. PubMed ID: 23110205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renovascular hypertension and
    Kim JY; Cho H
    Clin Nephrol; 2021 Aug; 96(2):105-111. PubMed ID: 33769276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of genotype and phenotype studies to confirm the predictive role of the RNF213 p.R4810K variant for moyamoya disease.
    Wang Y; Yang L; Wang X; Zeng F; Zhang K; Zhang Q; Liu M; Liu S; Shang M; Li Q; Yang Y; Liang M; Liu W
    Eur J Neurol; 2021 Mar; 28(3):823-836. PubMed ID: 33175469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNF213 rare variants in an ethnically diverse population with Moyamoya disease.
    Cecchi AC; Guo D; Ren Z; Flynn K; Santos-Cortez RL; Leal SM; Wang GT; Regalado ES; Steinberg GK; Shendure J; Bamshad MJ; ; Grotta JC; Nickerson DA; Pannu H; Milewicz DM
    Stroke; 2014 Nov; 45(11):3200-7. PubMed ID: 25278557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between p.R4810K Variant and Postoperative Collateral Formation in Patients with Moyamoya Disease.
    Ge P; Ye X; Liu X; Deng X; Wang J; Wang R; Zhang Y; Zhang D; Zhang Q; Zhao J
    Cerebrovasc Dis; 2019; 48(1-2):77-84. PubMed ID: 31578010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review of the Pertinent Literature.
    Zhang Q; Liu Y; Yu L; Duan R; Ma Y; Ge P; Zhang D; Zhang Y; Wang R; Wang S; Zhao Y; Cao Y; Liu X; Deng X; Zhao J; Zhang X
    World Neurosurg; 2017 Mar; 99():701-708.e1. PubMed ID: 28063898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of RNF213 polymorphism and cortical hyperintensity sign on fluid-attenuated inversion recovery images after revascularization surgery for moyamoya disease: possible involvement of intrinsic vascular vulnerability.
    Uchino H; Ito M; Tokairin K; Tatezawa R; Sugiyama T; Kazumata K; Fujimura M
    Neurosurg Rev; 2023 May; 46(1):119. PubMed ID: 37166684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic Interaction of Thyroid Autoantibodies and Ring Finger Protein 213 Variant in Moyamoya Disease.
    Thamamongood T; Hara S; Akagawa H; Inaji M; Tanaka Y; Nariai T; Maehara T
    Neurol Med Chir (Tokyo); 2024 Jan; 64(1):43-49. PubMed ID: 38057092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality.
    Hitomi T; Habu T; Kobayashi H; Okuda H; Harada KH; Osafune K; Taura D; Sone M; Asaka I; Ameku T; Watanabe A; Kasahara T; Sudo T; Shiota F; Hashikata H; Takagi Y; Morito D; Miyamoto S; Nakao K; Koizumi A
    Biochem Biophys Res Commun; 2013 Oct; 439(4):419-26. PubMed ID: 23994138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease.
    Moteki Y; Onda H; Kasuya H; Yoneyama T; Okada Y; Hirota K; Mukawa M; Nariai T; Mitani S; Akagawa H
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25964206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians.
    Guey S; Kraemer M; Hervé D; Ludwig T; Kossorotoff M; Bergametti F; Schwitalla JC; Choi S; Broseus L; Callebaut I; Genin E; Tournier-Lasserve E;
    Eur J Hum Genet; 2017 Aug; 25(8):995-1003. PubMed ID: 28635953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and Angiographic Features of Patients with Moyamoya Disease and the p.R4810K Heterozygous Variant.
    Zhang Q; Zhang D; Wang R; Liu Y; Zhang Y; Wang S; Zhao J
    World Neurosurg; 2016 Jun; 90():530-538.e3. PubMed ID: 26806063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can Moyamoya Disease Susceptibility Gene Affect Extracranial Systemic Artery Stenosis?
    Nomura S; Aihara Y; Akagawa H; Chiba K; Yamaguchi K; Kawashima A; Okada Y; Kawamata T
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104532. PubMed ID: 31806452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posterior circulation involvement and collateral flow pattern in moyamoya disease with the RNF213 polymorphism.
    Kim WH; Kim SD; Nam MH; Jung JM; Jin SW; Ha SK; Lim DJ; Lee HB
    Childs Nerv Syst; 2019 Feb; 35(2):309-314. PubMed ID: 30283986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Posterior cerebral artery involvement in unilateral moyamoya disease is exclusively ipsilateral and influenced by RNF213 mutation gene dose: The SUPRA Japan study: PCA involvement in unilateral moyamoya.
    Mineharu Y; Takagi Y; Koizumi A; Morimoto T; Funaki T; Hishikawa T; Araki Y; Hasegawa H; Takahashi JC; Kuroda S; Houkin K; Miyamoto S;
    J Stroke Cerebrovasc Dis; 2024 Feb; 33(2):107513. PubMed ID: 38141320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new horizon of moyamoya disease and associated health risks explored through RNF213.
    Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S
    Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.